SUMO2/3 promotes the progression and oxaliplatin resistance of colorectal cancer through facilitating the SUMOylation at Ku80‐K307
Authors:
- 20 June 2023
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 49 (6) , 1158-1173
Abstract
Colorectal cancer (CRC) is one of the most prevalent cancers worldwide and is typically treated with the FOLFOX regimen (folinic acid, 5‐fluorouracil, and oxaliplatin). However, oxaliplatin resistance remains a serious clinical problem. In the present study, we found that SUMO2/3 was overexpressed in CRC tissues and exogenous overexpression of SUMO2/3 promoted CRC cell proliferation, extension, and invasion and positively regulated the cell cycle. In contrast, SUMO2/3 gene knockdowns inhibited migration and repressed cell viability in vitro and in vivo. In addition, we found that SUMO2/3 was recruited to the cell nucleus and suppressed oxaliplatin‐induced apoptosis of CRC cells. Moreover, Ku80, a DNA‐binding protein essential for the repair of DNA double‐strand breaks, was confirmed to bind with SUMO2/3. Notably, Ku80 undergoes SUMOylation at K307 by SUMO2/3 and this correlated with apoptosis in CRC cells suffering oxaliplatin stress. Collectively, we found that SUMO2/3 plays a specific role in CRC tumorigenesis and acts through Ku80 SUMOylation which is linked with the development of CRC‐oxaliplatin resistance.Keywords
Funding Information
- National Natural Science Foundation of China (81903660)
This publication has 43 references indexed in Scilit:
- Global patterns and trends in colorectal cancer incidence and mortalityGut, 2016
- NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylationOncogene, 2014
- The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic DrugsCell Reports, 2014
- Stress-induced Phosphorylation of Thr486 in c-Myb by p38 Mitogen-activated Protein Kinases Attenuates Conjugation of SUMO-2/3Journal of Biological Chemistry, 2013
- Rap80 Protein Recruitment to DNA Double-strand Breaks Requires Binding to Both Small Ubiquitin-like Modifier (SUMO) and Ubiquitin ConjugatesJournal of Biological Chemistry, 2012
- Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)Genes & Development, 2011
- Thymosin β4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80Annals of the New York Academy of Sciences, 2010
- SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative StressJournal of Biological Chemistry, 2010
- Accumulation of Ku80 proteins at DNA double-strand breaks in living cellsExperimental Cell Research, 2008
- Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9Journal of Biological Chemistry, 2001